Your browser doesn't support javascript.
loading
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson's Disease.
Mueller, Karsten; Jech, Robert; Ballarini, Tommaso; Holiga, Stefan; Ruzicka, Filip; Piecha, Fabian A; Möller, Harald E; Vymazal, Josef; Ruzicka, Evzen; Schroeter, Matthias L.
Affiliation
  • Mueller K; Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany. karstenm@cbs.mpg.de.
  • Jech R; Department of Neurology - Center for interventional therapy of movement disorders, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. jech@cesnet.cz.
  • Ballarini T; Department of Radiology, Na Homolce Hospital, Prague, Czech Republic. jech@cesnet.cz.
  • Holiga S; Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
  • Ruzicka F; Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
  • Piecha FA; Department of Neurology - Center for interventional therapy of movement disorders, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Möller HE; Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
  • Vymazal J; Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
  • Ruzicka E; Department of Radiology, Na Homolce Hospital, Prague, Czech Republic.
  • Schroeter ML; Department of Neurology - Center for interventional therapy of movement disorders, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Cerebellum ; 18(2): 212-224, 2019 Apr.
Article in En | MEDLINE | ID: mdl-30298443
ABSTRACT
Levodopa has been the mainstay of symptomatic therapy for Parkinson's disease (PD) for the last five decades. However, it is associated with the development of motor fluctuations and dyskinesia, in particular after several years of treatment. The aim of this study was to shed light on the acute brain functional reorganization in response to a single levodopa dose. Functional magnetic resonance imaging (fMRI) was performed after an overnight withdrawal of dopaminergic treatment and 1 h after a single dose of 250 mg levodopa in a group of 24 PD patients. Eigenvector centrality was calculated in both treatment states using resting-state fMRI. This offers a new data-driven and parameter-free approach, similar to Google's PageRank algorithm, revealing brain connectivity alterations due to the effect of levodopa treatment. In all PD patients, levodopa treatment led to an improvement of clinical symptoms as measured with the Unified Parkinson's Disease Rating Scale motor score (UPDRS-III). This therapeutic effect was accompanied with a major connectivity increase between cerebellar brain regions and subcortical areas of the motor system such as the thalamus, putamen, globus pallidus, and brainstem. The degree of interconnectedness of cerebellar regions correlated with the improvement of clinical symptoms due to the administration of levodopa. We observed significant functional cerebellar connectivity reorganization immediately after a single levodopa dose in PD patients. Enhanced general connectivity (eigenvector centrality) was associated with better motor performance as assessed by UPDRS-III score. This underlines the importance of considering cerebellar networks as therapeutic targets in PD.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Levodopa / Cerebellum / Antiparkinson Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cerebellum Journal subject: CEREBRO Year: 2019 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Levodopa / Cerebellum / Antiparkinson Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cerebellum Journal subject: CEREBRO Year: 2019 Type: Article Affiliation country: Germany